Literature DB >> 25959739

Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice.

Marissa A Bowden1, Greg H Tesch2,3, Tracey L Julius1, Sarah Rosli1, Jane E Love1, Rebecca H Ritchie1,3.   

Abstract

OBJECTIVE: Emerging evidence suggests female type 2 diabetes (T2DM) patients may fare worse than males with respect to cardiovascular complications. Hence the impact of sex on relative progression of left ventricular (LV) remodeling in obese db/db mice was characterized.
METHODS: The changes in parameters of LV hypertrophy (heart weight, pro-hypertrophic gene expression, cardiomyocyte size) and fibrosis (LV collagen deposition and oxidative stress), in parallel with body weight and blood glucose and lipid profiles, in male and female db/db T2DM mice, at 10, 14, and 18 weeks of age, were determined.
RESULTS: Diabesity-induced cardiac remodeling was at least comparable in female (compared to male) mice. Females exhibited enhanced systemic oxidative stress and nonesterified fatty acid levels. Progression of LV pro-hypertrophic (β-myosin heavy chain, B-type natriuretic peptide) and pro-oxidant gene expression (NADPH oxidase subunit Nox2, plasminogen activator inhibitor-1 PAI-I) was, however, exaggerated in females when expressed relative to 10-week-old db/db mice. Increased cardiomyocyte width was also evident earlier in db/db females than males. No other gender differences were observed.
CONCLUSIONS: Progressive, age-dependent development of cardiac remodeling in db/db mice parallels impairments in glucose handling and oxidative stress. Certain aspects of the T2DM-induced LV remodeling response may have an earlier and/or exaggerated onset in diabetic females.
© 2015 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25959739     DOI: 10.1002/oby.21072

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  11 in total

1.  Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Ravi V Shah; Amanda Anderson; Jingzhong Ding; Matthew Budoff; Oliver Rider; Steffen E Petersen; Majken Karoline Jensen; Manja Koch; Matthew Allison; Nadine Kawel-Boehm; Jessica Wisocky; Michael Jerosch-Herold; Kenneth Mukamal; João A C Lima; Venkatesh L Murthy
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

Review 2.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

3.  Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats.

Authors:  Indira Purushothaman; Ian S Zagon; Joseph W Sassani; Patricia J Mclaughlin
Journal:  Exp Ther Med       Date:  2021-04-28       Impact factor: 2.447

Review 4.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

Authors:  Alexandra Kautzky-Willer; Jürgen Harreiter; Giovanni Pacini
Journal:  Endocr Rev       Date:  2016-05-09       Impact factor: 19.871

5.  Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

Authors:  Javad Habibi; Annayya R Aroor; James R Sowers; Guanghong Jia; Melvin R Hayden; Mona Garro; Brady Barron; Eric Mayoux; R Scott Rector; Adam Whaley-Connell; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

6.  Association between Diastolic Dysfunction with Inflammation and Oxidative Stress in Females ob/ob Mice.

Authors:  Michelle Sartori; Filipe F Conti; Danielle da Silva Dias; Fernando Dos Santos; Jacqueline F Machi; Zaira Palomino; Dulce E Casarini; Bruno Rodrigues; Kátia De Angelis; Maria-Claudia Irigoyen
Journal:  Front Physiol       Date:  2017-08-23       Impact factor: 4.566

7.  Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia.

Authors:  Chanchal Chandramouli; Melissa E Reichelt; Claire L Curl; Upasna Varma; Laura A Bienvenu; Parisa Koutsifeli; Antonia J A Raaijmakers; Miles J De Blasio; Cheng Xue Qin; Alicia J Jenkins; Rebecca H Ritchie; Kimberley M Mellor; Lea M D Delbridge
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

8.  G protein-coupled receptor kinase-2: A potential biomarker for early diabetic cardiomyopathy.

Authors:  Shuiqing Lai; Xiaoying Fu; Shufen Yang; Shuting Zhang; Qiuxiong Lin; Mengzhen Zhang; Hongmei Chen
Journal:  J Diabetes       Date:  2019-11-03       Impact factor: 4.006

Review 9.  Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.

Authors:  Anupam Mittal; Rajni Garg; Ajay Bahl; Madhu Khullar
Journal:  Front Cardiovasc Med       Date:  2021-12-16

Review 10.  Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.

Authors:  Ryan Toedebusch; Anthony Belenchia; Lakshmi Pulakat
Journal:  Front Physiol       Date:  2018-05-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.